Adavosertib (MK-1775) is a small-molecule inhibitor of WEE1 kinase, a regulator of the G2/M cell cycle checkpoint, being investigated for its potential to sensitize cancer cells to DNA-damaging therapies… Read more
Adavosertib (MK-1775) is a small-molecule inhibitor of WEE1 kinase, a regulator of the G2/M cell cycle checkpoint, being investigated for its potential to sensitize cancer cells to DNA-damaging therapies in various solid tumors. Analytical laboratories require high-quality reference standards for this compound, including metabolites and impurities, to support rigorous pharmaceutical development and quality control protocols. Stable isotope labelled versions, such as deuterated analogues, are essential for accurate quantification during bioanalytical method validation and pharmacokinetic studies, serving as internal standards in mass spectrometry workflows. Impurity standards, including N-desmethyl and N-nitroso derivatives, facilitate impurity profiling and stability testing to ensure regulatory compliance and product safety. These reference materials provide the necessary analytical foundation for characterizing drug substance purity, identifying degradation pathways, and monitoring potential contaminants throughout the drug manufacturing process.